EDITORIAL
Published on 07 Apr 2022
Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity
doi 10.3389/fmolb.2022.859821
- 1,000 views
- 3 citations
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds with a High Level of Selectivity of Action and Low Toxicity
Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds with a High Level of Selectivity of Action and Low Toxicity
8,086
Total downloads
36k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Dec 2021
1H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina IIgly on MDA-MB-231 Breast Tumor Cells
doi 10.3389/fmolb.2021.742859
- 2,196 views
- 11 citations
ORIGINAL RESEARCH
Published on 04 Jun 2021
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
doi 10.3389/fmolb.2021.675179
- 11,979 views
- 35 citations
REVIEW
Published on 04 Feb 2021
Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency
doi 10.3389/fmolb.2020.627272
- 15,133 views
- 109 citations
ORIGINAL RESEARCH
Published on 12 Jan 2021
The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
doi 10.3389/fmolb.2020.595830
- 3,340 views
- 8 citations
